Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Bitcoin popularized blockchain concepts, but early ideas influenced both. This piece names contributors and explains the initial timeline.
14,741 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A shift is sweeping real estate finance: lenders are resetting terms, buyers are adjusting plans, and landlords are l...
A growing number of would-be investors miss Buffett’s simple path to wealth because they cannot save enough to invest...
Bilt rolls out an AI-driven Neighborhood Concierge to challenge Amazon in the home-commerce space, promising seamless...
Public headlines rarely tell the whole story about the economy or your wallet. This article breaks down how political...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
Broadcom is trading around $315, down about 9% year-to-date, as analysts push a $454 12-month target on accelerating ...
When you turn 73, the game changes: you must take a required minimum distribution (RMD). This article weighs the pros...
A 6% weekly pullback can feel painful, but for patient buyers, this growth stock march story is about resilience, rev...
Nio stunned investors with its first quarterly net profit, driving a sharp rally on a market day shaped by mixed indi...
Two frontier AI firms are tipped for 2026 IPOs, with lofty valuations and aggressive monetization bets, as markets we...
A new wave of policy proposals seeks to curb large landlords by banning institutional investors from buying single-fa...